Contract Research Organizations (CRO) in Latin America are key strategic partners to many pharmaceutical and biotech companies from North America and Europe. CRO’s allows these firms to concentrate efforts in their core skills, mostly related to manufacturing, marketing and sales. In the continuous race to optimize resources, cost reduction generally results the very first variable to be adjusted. Areas such as legal affairs and logistics have been pioneers when their specific duties have been outsourced into the hands of organizations more specialized in those key activities.
Beginning 20 years ago, healthcare enterprises began using outsourcing providers to assist in areas like Regulatory Submissions, Patient Recruitment, Project Management and Clinical Monitoring. In recent years, Latin America has become an increasingly attractive destination.
First reports of CRO’s presence in countries such as Argentina and Brazil date from the mid 1990’s. Small local companies started by offering services to small pharma labs without large or proper R&D facilities, aiming to optimize resources during the always difficult and costly period of pre-market product development. Over the course of time, mergers and acquisitions began to create larger CRO operators.
Our commitment is to offer an alternative to the highly complicated, expensive and sometimes chaotic process that Biotech, Pharmaceutical and Medical Device companies have to endure in the United States. By providing the industry with our infrastructure in Latin America, we offer an easier path to launch clinical trials and studies following FDA standards. We define ourselves as a unique team, capable of blending our academic background with a global business mindset to bring the highest standard of quality and operational excellence into clinical research in Latin America. With headquarters in Monterrey, Mexico, Cohortias has built an extensive and highly reputable network of sites which can access patients in a timely manner and can operate within a standard-of-care comparable to the U.S. healthcare system.
Activa Cro is a Regional Contract Research Organization operating in Latin America (South American Cro), that provides clinical research services to the pharmaceutical , biotechnology and medical device/diagnostic industry in Argentina, Brazil, Chile, Colombia, México, Panama, Perú, Ecuador and Uruguay.
Covance Inc., a global contract research organization (CRO), is the world’s most comprehensive drug development company. Covance Inc., the drug development business of LabCorp®, is the world’s most comprehensive drug development company, dedicated to advancing healthcare and delivering Solutions Made Real®. Our unique perspectives, built from decades of scientific expertise and precision delivery of the largest volume of drug development data in the world, along with our innovative technology solutions, help our clients identify new approaches and anticipate tomorrow’s challenges as they evolve. Together with our clients, Covance transforms today’s healthcare challenges into tomorrow’s solutions. We also offer laboratory testing services to the chemical/agrochemical industries and are a market leader in toxicology services, central laboratory services, discovery services and a top global provider of Phase III clinical trial management services.
Since our foundation in Dublin, Ireland in 1990, our mission has been to help our clients to accelerate the development of drugs and devices that save lives and improve quality of life.We are a global provider of outsourced development and commercialisation services to pharmaceutical, biotechnology, medical device and government and public health organisations. We focus our innovation on the factors that are critical to our clients – reducing time to market, reducing cost and increasing quality – and our global team of experts has extensive experience in a broad range of therapeutic areas. ICON has been recognised as one of the world’s leading Contract Research Organisations through a number of high-profile industry awards.
IMS Health and Quintiles are now IQVIA, a world leader in using data, technology, advanced analytics and expertise to help customers drive healthcare – and human health – forward. Together with the companies we serve, we are enabling a more modern, more effective and more efficient healthcare system, and creating breakthrough solutions that transform business and patient outcomes.n help accelerate progress and achievements. Others are developing these medical breakthroughs. We do our part by using breakthroughs in insights, technology and human intelligence to reimagine and deliver ways to help make them a reality. It’s bigger than better clinical trials. Or advances in technologies and analytics. Or faster insights. It’s about exploring a new path to better health outcomes via Human Data Science. It’s about harnessing the power of the IQVIA CORE™ to channel the insights, commercial and scientific depth, and executional expertise that drive maximum value for our customers. Motivated by the industry we help, we’re committed to providing solutions that enable life sciences companies to innovate with confidence, maximize opportunities, and, ultimately, drive human health outcomes forward.
For over 35 years, PAREXEL has proven to be a trusted partner for the complex development journey required of biopharmaceutical and medical device companies. We’re also an astute guide, able to simplify that journey for our clients, so safe new products can reach patients more quickly.